Dr. Jill P. Smith, M.D.

Dr. Jill Smith is an Emeritus Professor of Medicine in the Gastroenterology Division of the Department of Medicine, Hershey Medical Center, Penn State University. Over the course of her twenty two years at Penn State University she has mentored thirty eight post-doctoral fellows and students, thereby ensuring continuing excellence in medicine for future generations. Simultaneously, in her role as Professor of Cellular and Molecular Physiology she has taught and conducted basic science research in the graduate school. As a physician, she also treats patients with Inflammatory Bowel Diseases.

Dr. Smith has a long track record of conducting pre-clinical scientific research and translational clinical trials in patients with a focus on disorders of the gastrointestinal tract and pancreas. For over two decades, she has conducted industry-sponsored trials and investigator-initiated research involving inflammatory bowel disease. Dr. Smith was the first ever researcher to carry out a clinical trial of Low Dose Naltrexone (LDN). The results of the successful trial in patients suffering from Crohn's disease has spearheaded ongoing clinical trials by other researchers at several institutions worldwide.

Dr. Smith was elected as the first woman President of the American Pancreas Association. For three years, she served as the Chairman of the American Gastroenterology Association's Research Committee and she currently serves on National Institutes of Health review panels for research grants. Dr. Smith has chaired a National Cancer Institute workshop on pancreatic cancer and her expertise in pancreatic cancer and translational research has made her a sought-after international speaker in these fields.

To view her bio, click on Dr. Jill P. Smith's profile

To view her published articles, click on Dr. Jill P. Smith’s Work